Skeletal involvement in patients with diabetes mellitus

Diabetes/Metabolism Research and Reviews

Volumn 20, Issue 3, 2004, Pages 196-204

  Carnevale, Vincenzo ^a   Romaglino, Elisabetta ^b   D'Erasmo, Emilio ^b  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bone mineral density; Bone turnover; Calcium homeostasis; Diabetes mellitus; Fracture risk

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CALCIUM; PARATHYROID HORMONE; SOMATOMEDIN C; VITAMIN D;

ADIPOSE TISSUE; BONE DENSITY; BONE INJURY; BONE MASS; BONE MINERAL; BONE TISSUE; CALCIUM ABSORPTION; CALCIUM HOMEOSTASIS; CALCIUM URINE LEVEL; COHORT ANALYSIS; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HIP FRACTURE; HORMONE DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE ABSORPTION; METABOLIC PARAMETERS; MINERAL METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOPOROSIS; PARATHYROID HORMONE RELEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; URINARY EXCRETION;

BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE REMODELING; DIABETES COMPLICATIONS; DIABETES MELLITUS; FRACTURES, BONE; HUMANS; RISK FACTORS;

EID: 2642565953     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.449     Document Type: Review

References (110)

1. Morrison LB, Bogart IK. Bone development in diabetic children: a roentgen study. Am J Med Sci 1927; 174: 313-319.
2. Albright F, Reifenstein EC. The Parathyroid Glands and Metabolic Bone Disease: Selected Studies, Williams & Wilkins: Baltimore, 1948.
3. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2002; 25(1): S5-S20.
4. McNair P, Madsbad S, Christensen MS, et al. Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis. Acta Endocrinol 1979; 90: 463-472.
5. McNair P, Christensen MS, Christiansen C, Madsbad S, Transbol I. Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis. Eur J Clin Invest 1982; 12: 81-85.
6. McNair P. Bone mineral metabolism in human type 1 (insulin dependent) diabetes mellitus. Dan Med Bull 1988; 35: 109-121.
7. Raskin P, Stevenson MRM, Barilla DE, Pak CYC. The hypercalciuria of diabetes mellitus: its amelioration with insulin. Clin Endocrinol 1978; 9: 329-335.
8. Kemink SAG, Hermus ARMM, Swinkels LMJW, Lutterman JA, Smals AGH. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest 2000; 23: 295-303.
9. Wood RJ, Allen LH, Bronner F. Regulation of calcium metabolism in streptozotocin-induced diabetes. Am J Physiol 1984; 247: R120-R123.
10. Bouillon R. Diabetic bone disease. Calcif Tissue Int 1991; 49: 155-160.
11. Heath HIII, Lambert PW, Service FJ, Arnaud SB. Calcium homeostasis in diabetes mellitus. J Clin Endocrinol Metab 1979; 49: 462-466.
12. Lunt H, Florkowski CM, Cook HB, Whitehead MR. Bone mineral density, type 1 diabetes, and coeliac disease. Diabetes Care 2001; 24: 791-792.
13. Cronin CC, Shanahan F. Insulin-dependent diabetes mellitus and coeliac disease. Lancet 1997; 349: 1096-1097.
14. Collin P, Kaukinen K, Välimäki M, Salmi J. Endocrinological disorders and celiac disease. Endocr Rev 2002; 23: 464-483.
15. Fogh-Andersen N, McNair P, Moller-Petersen J, Madsbad S. Serum calcium fractions in diabetes mellitus. Clin Chem 1982; 28: 2073-2076.
16. Gregorio F, Cristallini S, Santeusanio P, Filipponi F, Fumelli P. Osteopenia associated with non-insulin dependent diabetes mellitus. What are the causes? Diabetes Res Clin Pract 1994; 23: 43-54.
17. Piepkorn B, Kann P, Forst T, Andreas J, Pfützner A, Beyer J. Bone mineral density and bone metabolism in diabetes mellitus. Horm Metab Res 1997; 29: 584-591.
18. Schneider A, Shane E. Osteoporosis secondary to illnesses and medications. In Osteoporosis (2nd edn), vol 2. Marcus R, Feldman D, Kelsey J (eds). Academy Press: San Diego, 2001; 303-326.
19. McNair P, Christensen MS, Madsbad S, Christiansen C, Transbol I. Hypoparathyroidism in diabetes mellitus. Acta Endocrinol 1981; 96: 81-86.
20. Schwarz P, Sorensen HA, Momsen G, Friis T, Transbol I, McNair P. Hypocalcemia and parathyroid hormone responsiveness in diabetes mellitus: a tri-sodium-citrate clamp study. Acta Endocrinol 1992; 126: 260-263.
21. Clowes JA, Robinson RT, Heller SR, Eastell R, Blumsohn A. Acute changes of bone turnover and PTH induced by insulin and glucose: euglycemic and hypoglycemic hyperinsulinemic clamp studies. J Clin Endocrinol Metab 2002; 87: 3324-3329.
22. D'Erasmo E, Pisani D, Ragno A, Raejntroph N, Vecci E, Acca M. Calcium homeostasis during oral glucose load in healthy women. Horm Metab Res 1999; 31: 271-273.
23. Bertelloni S. The parathyroid hormone-1,25-dihydroxyvitamin D endocrine system and magnesium status in insulin-dependent diabetes mellitus: current concepts. Magnes Res 1992; 5: 45-51.
24. Inaba M, Nagasue K, Okuno S, et al. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus. Am J Kidney Dis 2002; 39: 1261-1269.
25. Christiansen C, Christensen MS, McNair P, Nielsen B, Madsbad S. Vitamin D metabolites in diabetic patients: decreased serum concentration of 24,25-dihydroxyvitamin D. Scand J Clin Lab Invest 1982; 42: 487-491.
26. Nyomba BL, Verhaeghe J, Thomasset M, Lissens W, Bouillon R. Bone mineral homeostasis in spontaneously diabetic BB rats. Abnormal vitamin D metabolism and impaired active intestinal calcium absorption. Endocrinology 1989; 124: 565-572.
27. Baynes KC, Boucher BJ, Feskens EJ, Kromhout D. Vitamin D glucose tolerance and insulinaemia in elderly men. Diabetologia 1997; 40: 344-347.
28. Hollis BW. Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it. Calcif Tissue Int 1996; 58: 4-5.
29. Storm TL, Sorensen OH, Lund B, et al. Vitamin D metabolism in insulin-dependent diabetes mellitus. Metab Bone Dis Relat Res 5: 1983-1984.; 107-110.
30. Hampson G, Evans C, Petitt RJ, et al. Bone mineral density, collagen type 1α1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia 1998; 41: 1314-1320.
31. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777-783.
32. Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome "X"? Br J Nutr 1998; 79: 315-327.
33. Mc Grath J. Does "imprinting" with low prenatal vitamin D contribute to the risk of various adult disorders? Med Hypotheses 2001; 56: 367-371.
34. Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358: 1500-1503.
35. Brown AJ, Dusso A, Slatopolsky E. Vitamin D. Am J Physiol 1999; 277: F157-F175.
36. Zmuda JM, Cauley JA, Ferrel RE. Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 2000; 22: 203-217.
37. Ortlepp JR, Lauscher J, Hoffmann R, Hanrath P, Joost HG. The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabet Med 2001; 18: 842-845.
38. Ma X, Jing Y, Qin W, et al. Vitamin D receptor gene polymorphism and bone mineral density in patients with type 2 diabetes mellitus. Chin Med J 2001; 114: 1213-1215.
39. Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes and metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 2002; 51: 356-359.
40. Lee JK, Park C, Kimm K, Rutherford MS. Genome-wide multilocus analysis for immune-mediated complex diseases. Biochem Biophys Res Commun 2002; 295: 771-773.
41. Raisz LG. Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 1988; 318: 818-828.
42. Falkner B, Sherif K, Sumner A, Kushner H. Hyperinsulinism and sex hormones in young adult African Americans. Metabolism 1999; 48: 107-112.
43. Maturana MA, Spritzer PM. Association between hyperinsulinemia and endogenous androgen levels in peri- and postmenopausal women. Metabolism 2002; 51: 238-243.
44. Phillips GP, Tuck CH, Jing TY, et al. Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women. Diabetes Care 2000; 23: 74-79.
45. Jehle PM, Jehle DR, Mohan S, Bohm BO. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in type 1 and type 2 diabetes mellitus patients. J Endocrinol 1998; 159: 297-306.
46. McCarthy AD, Etcheverry SB, Cortizo AM. Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development. Acta Diabetol 2001; 38: 113-122.
47. Leidig-Bruckner G, Ziegler R. Diabetes mellitus a risk for osteoporosis? Exp Clin Endocrinol Diabetes 2001; 109(2): S493-S514.
48. Longope C, Baker R, Johnston CC Jr. Androgen and estrogen metabolism: relationship to obesity. Metabolism 1986; 35: 235-237.
49. Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 1998; 83: 2266-2274.
50. Mundy G. Secondary osteoporosis: the potential relevance of leptin and low body weight. Ann Intern Med 2000; 133: 828-830.
51. Thomas T, Burguera B. Is leptin the link between fat and bone mass? J Bone Miner Res 2002; 17: 1563-1569.
52. Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999; 140: 1630-1638.
53. Burguera B, Hofbauer L, Thomas T, et al. Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 2001; 142: 3546-3553.
54. Yamauchi M, Sugimoto T, Yamaguchi T, et al. Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol 2001; 55: 341-347.
55. Zoico E, Zamboni M, Adami S, et al. Relationship between leptin levels and bone mineral density in the elderly. Clin Endocrinol 2003; 59: 97-103.
56. Ruhl CE, Everhart JE. Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res 2002; 17: 1896-1903.
57. Yokota T, Meka CS, Medina KL, et al. Paracrine regulation of fat cell formation in bone marrow cultures via adiponectin and prostaglandins. J Clin Invest 2002; 109: 1303-1310.
58. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2001; 2: 165-171.
59. Wientroub S, Eisenberg D, Tardiman R, Weissman SI, Salama R. Is diabetic osteoporosis due to microangiopathy? Lancet 1980; ii: 983.
60. Vogt MT, Cauley JA, Kuller LH, Nevitt MC. Bone mineral density and blood flow to the lower extremities: the Study of osteoporotic fractures. J Bone Miner Res 1997; 12: 283-289.
61. Lerner UH. The role of skeletal nerve fibers in bone metabolism. The Endocrinologist 2000; 10: 377-382.
62. Parfitt AM. The mechanism of coupling: a role for the vasculature. Bone 2000; 26: 319-323.
63. Leibowitz G, Tsur A, Chayen SD, et al. Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol 1996; 44: 717-722.
64. Reincke M. Subclinical Cushing's syndrome. Endocrinol Metab Clin N Am 2000; 29: 43-56.
65. Terzolo M, Pia A, Alí A, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 2002; 87: 998-1003.
66. Chiodini I, Torlontano M, Carnevale V, et al. Bone loss in adrenal incidentalomas: a longitudinal study. J Clin Endocrinol Metab 2001; 86: 5337-5341.
67. Pedrazzoni M, Ciotti G, Pioli G, et al. Osteocalcin levels in diabetic subjects. Calcif Tissue Int 1989; 45: 331-336.
68. Bouillon R, Bex M, Van Herck E, et al. Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus. J Clin Endocrinol Metab 1995; 80: 1194-1202.
69. Isaia GC, Ardissone P, Di Stefano M, et al. Bone metabolism in type 2 diabetes mellitus. Acta Diabetol 1999; 36: 35-38.
70. Erbagci AB, Araz M, Erbagci A, Tarakcioglu M, Namiduru ES. Serum prolidase activity as a marker of osteoporosis in type 2 diabetes mellitus. Clin Biochem 2002; 35: 263-268.
71. Krakauer JC, Mc Kenna MJ, Buderer NF, Rao S, Whitehouse FW, Parfitt AM. Bone loss and bone turnover in diabetes. Diabetes 1995; 44: 775-782.
72. Levin ME, Boisseau VC, Avioli LV. Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N Engl J Med 1976; 294: 241-245.
73. Hui Sl, Epstein S, Johnston CCA. Prospective study on bone mass in patients with type I diabetes. J Clin Endocrinol Metab 1985; 60: 74-80.
74. Lopez-Ibarra PJ, Pastor MM, Escobar Jimenez F, et al. Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus. Endocr Pract 2001; 7: 346-351.
75. Mc Nair P, Christiansen C, Christensen MS, et al. Development of bone mineral loss in insulin-treated diabetes: a 1 1/2 years follow-up study in sixty patients. Eur J Clin Invest 1981; 11: 55-59.
76. Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994; 8: 1137-1141.
77. Munoz-Torres M, Jodar E, Escobar-Jimenez F, Lopez-Ibarra P, Luna J. Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus. Calcif Tissue Int 1996; 58: 316-319.
78. Tuominen JT, Impivaara O, Puukka P, Rönnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 1999; 22: 1196-1200.
79. Gallagher SJ, Fenner JA, Fisher BM, et al. An evaluation of bone density and turnover in premenopausal women with type I diabetes mellitus. Diabet Med 1993; 10: 129-133.
80. Mathiassen B, Nielsen S, Johansen JS, et al. Long-term bone loss in insulin-dependent diabetic patients with microvascular complications. J Diabetes Compt 1990; 4: 145-149.
81. Forst T, Pfützner A, Kann P, et al. Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus. Diabet Med 1995; 12: 875-879.
82. Campos-Pastor MM, Lopez-Ibarra PJ, Escobar-Jimenez F, Serrano Pardo MD, García-Cervigon A. intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study. Osteoporos Int 2000; 11: 455-459.
83. Johnston CC, Hui SL, Longcope C. Bone mass and sex steroid concentrations in postmenopausal caucasian diabetics. Metabolism 1985; 34: 544-550.
84. Weinstock RS, Goland RS, Shane E, Clements TS, Lindsay R, Bilezikian JP. Bone mineral density in women with type II diabetes mellitus. J Bone Miner Res 1989; 4: 97-101.
85. Isaia G, Bodrato L, Carlevatto V, Mussetta M, Salamano G, Molinatti GM. Osteoporosis in type II diabetes. Acta Diabetol 1987; 24: 305-310.
86. Barrett-Connor E, Holbrook TL. Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. JAMA 1992; 268: 3333-3337.
87. Wakasugy M, Wakao R, Tawata M, Gan M, Koizumi K, Onaya T. Bone mineral density measured by dual x-ray absorptiometry in patients with non-insulin dependent diabetes mellitus. Bone 1993; 14: 29-33.
88. Van Daele PLA, Stolk RP, Burger H, et al., The Rotterdam Study. Bone density in non-insulin-dependent diabetes mellitus. Ann Intern Med 1995; 122: 409-414.
89. Schwartz AV, Sellmeyer DE, Ensrud KE, et al. Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 2001; 86: 32-38.
90. Lunt M, Masaryk P, Scheidt-Nave C, et al., The EVOS study. The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence. Osteoporos Int 2001; 12: 688-698.
91. Aoyagi K, Ross PD, Orloff J, Davis JW, Katagiri H, Wasnich RD. Low bone density is not associated with aortic calcification. Calcif Tissue Int 2001; 69: 20-24.
92. Vogt MT, San Valentin R, Forrest KYZ, Nevitt MC, Cauley JA. Bone mineral density and aortic calcification: the study of osteoporotic fractures. J Am Geriatr Soc 1997; 45: 140-145.
93. Kiss C, Szilagyi M, Paksy A, Poor G. Risk factors for diffuse idiopatic skeletal hyperostosis: a case-control study. Rheumatol (Oxf) 2002; 41; 27-30.
94. Ivers RQ, Cumming RG, Mitchell P, Peduto AJ. The Blue Mountains Eye Study. Diabetes and risk of fracture: the Blue Mountains Eye Study. Diabetes Care 2001; 24: 1198-1203.
95. Vogt MT, Cauley JA, Tomaino MM, Stone K, Williams JR, Herndon JH. The Study of Osteoporotic Fractures. Distal radius fractures in older women: a 10 years follow-up study of descriptive characteristics and risk factors. J Am Geriatr Soc 2001; 50: 97-103.
96. Melton LJIII, Achenbach SJ, O'Fallon WM, Khosla S. Secondary osteoporosis and the risk of distal forearm fractures in men and women. Bone 2002; 31: 119-125.
97. Forsén L, Meyer HE, Midthjell K, Edna T-H. Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health Survey. Diabetologia 1999; 42: 920-925.
98. Seeley DG, Kelsey J, Jergas M, Nevitt MC, The Study of Osteoporotic Fractures Research Group. Predictors of ankle and foot fractures in older women. J Bone Miner Res 1996; 11: 1347-1355.
99. Cummings SR, Melton LJ III. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002; 359: 1761-1767.
100. Heath H, Melton LJ, Chu CP. Diabetes mellitus and risk of skeletal fracture. N Engl J Med 1980; 303: 567-570.
101. Melchior TM, Sorensen H, Torp-Pedersen C. Hip and distal arm fracture rates in peri- and postmenopausal insulin-treated diabetic females. J Intern Med 1994; 236: 203-208.
102. Cummings SR, Nevitt MC, Browner WS, et al., Study of Osteoporotic Fractures Research Group. Risk factors for hip fracture in white women. N Engl J Med 1995; 332: 767-773.
103. Nicodemus KK, Folsom AR. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001; 24: 1192-1197.
104. Nisbeth U, Lindh E, Ljunghall S, Backman U, Fellstrom B. increased fracture rate in diabetes mellitus and females after renal transplantation. Transplantation 1999; 67: 1218-1222.
105. O'Shaughnessy FA, Dahl DC, Smith CL, Kasiske BL. Risk factors for fractures in kidney transplantation. Transplantation 2002; 74: 362-366.
106. Espallargues M, Sampietro-Colom L, Estrada MD, et al. Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a sistematic review of the literature. Osteoporos Int 2001; 12: 811-822.
107. Wallace C, Reiber GE, LeMaster J, et al. Incidence of falls, risk factors for falls, and fall-related fractures in individuals with diabetes and a prior foot ulcer. Diabetes Care 2002; 25: 1983-1986.
108. Keegan THM, Kelsey JL, Sidney S, Quesenberry CP Jr. Foot problems as risk factors for fractures. Am J Epidemiol 2002; 155: 926-931.
109. Nelson DA, Jacober SJ. Why do older women with diabetes have an increased fracture risk? J Clin Endocrinol Metab 2001; 86: 29-31.
110. Gregg EW, Yaffe K, Cauley JA, et al., for the Study of Osteoporotic Fractures Research Group. Is diabetes associated with cognitive impairment and cognitive decline among older women? Arch Intern Med 2000; 160: 174-180.